Antagonism of non-depolarising neuromuscular block: Current practice

Anaesthesia

Volumn 64, Issue SUPPL. 1, 2009, Pages 22-30

  Kopman, Aaron F ^a   Eikermann, M ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; ATROPINE; CHOLINESTERASE INHIBITOR; GLYCOPYRRONIUM BROMIDE; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; ROCURONIUM; VECURONIUM;

ASYSTOLE; BRADYCARDIA; BRONCHOSPASM; DECISION MAKING; DRUG ANTAGONISM; DRUG MONITORING; HEART ARRHYTHMIA; HUMAN; HYPOXEMIA; INTESTINE PRESSURE; LOW DRUG DOSE; MUSCLE FATIGUE; MUSCLE FUNCTION; NEUROMUSCULAR BLOCKING; PERIPHERAL NERVE; POSTOPERATIVE PERIOD; REVIEW; RISK ASSESSMENT; SIDE EFFECT; TACTILE DISCRIMINATION; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT OBSTRUCTION; XEROSTOMIA;

CHOLINESTERASE INHIBITORS; HUMANS; MONITORING, PHYSIOLOGIC; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE CARE;

EID: 61849146198     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2008.05867.x     Document Type: Review

References (66)

1. Cowan SL. The action of eserine-like and curare-like substances on the responses of frog's nerve-muscle preparations to repetitive stimulation. Journal of Physiology 1938; 93: 215-62.
2. Griffith HR, Johnson GE. The use of curare in general anesthesia. Anesthesiology 1942; 3: 412-20.
3. Cullen SC. Clinical and laboratory observations on the use of curare during inhalation anesthesia. Anesthesiology 1944; 5: 166-73.
4. Gray TC, Halton J. A milestone in anaesthesia? Proceedings of the Royal Society of Medicine 1946; 39: 400-10.
5. Gray TC, Rees GJ. The role of apnoea in anaesthesia for major surgery. British Medical Journal 1952; 2: 891-2.
6. Gray TC, Wilson F. The development and use of muscle relaxants in the United Kingdom. Anesthesiology 1959; 20: 519-29.
7. Kopman AF. The effect of resting muscle tension on the dose-effect relationship of d-tubocurarine: does preload influence the evoked EMG? Anesthesiology 1988; 69: 1003-5.
8. Mackintosh RR. Death following injection of neostigmine. British Medical Journal 1949; 1: 852.
9. Clutton-Brock J. Death following neostigmine. British Medical Journal 1949; 1: 1007.
10. Hill M. Death following neostigmine. British Medical Journal 1949; 2: 601.
11. Pooler HE. Atropine, neostigmine, and sudden deaths. Anaesthesia 1957; 12: 198-202.
12. Beecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery. Annals of Surgery 1954; 140: 2-35.
13. Churchill-Davidson HC. The d-tubocurarine dilemma. Anesthesiology 1965; 26: 132-3.
14. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. British Journal of Anaesthesia 2000; 84: 301-3.
15. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of non-depolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98: 1042-8.
16. Baillard C, Clec'h C, Catineau J, et al. Postoperative residual neuromuscular block: a survey of management. British Journal of Anaesthesia 2005; 95: 622-6.
17. Ali HH, Kitz RJ. Evaluation of recovery from non-depolarizing neuromuscular blockade using a digital neuromuscular analyser: preliminary report. Anesthesia and Analgesia 1973; 52: 740-4.
18. Brand JB, Cullen DJ, Wilson NE, Ali HH. Spontaneous recovery from non-depolarizing neuromuscular blockade: correlation between clinical and evoked responses. Anesthesia and Analgesia 1977; 56: 55-8.
19. Ali HH, Savarese JJ, Lebowitz PW, Ramsey FM. Twitch, tetanus, and train-of-four as indices of recovery from non-depolarizing neuromuscular blockade. Anesthesiology 1981; 54: 294-7.
20. Kopman AF, Yee PS, Neuman GG. Correlation of the train-of-four fade ratio with clinical signs and symptoms of residual curarization in awake volunteers. Anesthesiology 1997; 86: 765-71.
21. Eriksson LI, Sato M, Severinghaus JW. Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response. Anesthesiology 1993; 78: 693-9.
22. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans. Simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997; 87: 1035-43.
23. Eikermann M, Groeben H, Hüsing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 2003; 98: 1333-7.
24. Eikermann M, Vogt FM, Herbstreit F, et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. American Journal of Respiratory and Critical Care Medicine 2007; 175: 9-15.
25. Sacan O, White PF, Tufanogullari B, Klein K. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Anesthesia and Analgesia 2007; 104: 569-74.
26. Pratt CI. Bronchospasm after neostigmine. Anaesthesia 1988; 43: 248.
27. Hazizaj A, Hatija A. Bronchospasm caused by neostigmine. European Journal of Anaesthesiology 2006; 23: 85-6.
28. Sprague DH. Severe bradycardia after neostigmine in a patient taking propranolol to control paroxysmal atrial tachycardia. Anesthesiology 1975; 42: 208-10.
29. Sawasdiwipachai P, Laussen PC, McGowan FX, Smoot L, Casta A. Cardiac arrest after neuromuscular blockade reversal in a heart transplant infant. Anesthesiology 2007; 107: 663-5.
30. Beebe DS, Shumway SJ, Maddock R. Sinus arrest after intravenous neostigmine in two heart transplant recipients. Anesthesia and Analgesia 1994; 78: 779-82.
31. Bjerke RJ, Mangione MP. Asystole after intravenous neostigmine in a heart transplant recipient. Canadian Journal of Anaesthesia 2001; 48: 305-7.
32. Aitkenhead AR. Anaesthesia and bowel surgery. British Journal of Anaesthesia 1984; 56: 95-101.
33. Barany F, Jacobson B. Endoradiosonde study of propulsion and pressure activity induced by test meals, prostigmine, and diphenoxylate in the small intestine. Gut 1964; 5: 90-5.
34. Wilkins JL, Hardcastle JD, Mann CV, Kaufman L. Effects of neostigmine and atropine on motor activity of ileum, colon, and rectum of anaesthetized subjects. British Medical Journal 1970; 1: 793-4.
35. Payne JP, Hughes R, Al Azawi S. Neuromuscular blockade by neostigmine in anesthetized man. British Journal of Anaesthesia 1981; 52: 69-76.
36. Caldwell JE. Reversal of residual neuromuscular block with neotigmine at one to four hours after a single intubating dose of vecuronium. Anesthesia and Analgesia 1995; 80: 1168-74.
37. Yost CS, Maestrone E. Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor. Anesthesia and Analgesia 1994; 78: 520-6.
38. Legendre P, Ali DW, Drapeau P. Recovery from open channel block by acetylcholine during neuromuscular transmission in zebrafish. Journal of Neuroscience 2000; 20: 140-8.
39. Eikermann M, Fassbender P, Malhotra A, et al. Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function. Anesthesiology 2007; 107: 621-9.
40. Herbstreit F, Christof Ochterbeck C, Peters J, Eikermann M. Unwarranted administration of neostigmine increases upper airway collapsibility in humans. Anesthesiology 2008; 109: A1401.
41. Johnson RA, Harper NJ. Antagonism of moderate degrees of vecuronium-induced neuromuscular block by small doses of neostigmine. British Journal of Anaesthesia 1989; 62: 483-7.
42. Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia 2007; 62: 806-9.
43. Sorgenfrei IF, Viby-Mogensen J, Swiatek FA. [Does evidence lead to a change in clinical practice? Danish anaesthetists' and nurse anesthetists' clinical practice and knowledge of postoperative residual curarization]. Ugeskrift for Laeger 2005; 167: 3878-82.
44. Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M. [The use of neuromuscular monitoring in Germany]. Anaesthesist 2003; 52: 522-6.
45. Nava-Ocampo AA, Ramírez-Mora JC, Moyao-García D, Garduño-Espinosa J, Salmerón J. Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey. BMC Anesthesiology 2002; 2: 2.
46. Viby-Mogensen J, Jensen NH, Engbæk J, Ording H, Skovgaard LT, Chraemmer-Jorgensen B. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985; 63: 440-3.
47. Dupuis JY, Martin R, Tessonnier JM, Tétrault JP. Clinical assessment of the muscular response to tetanic nerve stimulation. Canadian Journal of Anaesthesia 1990; 37: 397-400.
48. Capron F, Fortier L, Racine S, Donati F. Tactile fade detection with hand or wrist stimulation using train-of-four, double-burst stimulation, 50-Hertz tetanus, 100-Hertz tetanus, and acceleromyography. Anesthesia and Analgesia 2006; 102: 1578-84.
49. Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M. Residual curarization in the recovery room after vecuronium. British Journal of Anaesthesia 2000; 84: 394-5.
50. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001; 56: 312-8.
51. McCaul C, Tobin E, Boylan JF, McShane AJ. Atracurium is associated with postoperative residual curarization. British Journal of Anaesthesia 2002; 89: 766-9.
52. Miller RD. How should residual neuromuscular blockade be detected? Anesthesiology 1989; 70: 379-80.
53. Shorten GD. Postoperative residual curarisation: incidence, aetiology and associated morbidity. Anaesthesia and Intensive Care 1993; 21: 782-9.
54. Berg H, Viby-Mogensen J, Roed J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. Acta Anaesthesiologica Scandinavica 1997; 41: 1095-103.
55. Pedersen T, Viby-Mogensen J, Ringsted C. Anesthetic practice and postoperative pulmonary complications. Acta Anaesthesiologica Scandinavica 1992; 36: 812-8.
56. Bevan DR, Smith CE, Donati F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology 1988; 69: 272-6.
57. Murphy GS, Szokol JW, Franklin M, Marymont JH, Avram MJ, Vender JS. Postanesthesia Care Unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium. Anesthesia and Analgesia 2004; 98: 193-200.
58. Murphy GS, Szokol JW, Marymount JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the Postanesthesia Care Unit. Anesthesia and Analgesia 2008; 107: 130-7.
59. Murphy GS, Szokol JW, Marymount JH, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008; 103: 389-98.
60. Arbous MS, Meursing A, van Kleef JW, et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005; 102: 257-68.
61. Warner MA. Perioperative mortality: intraoperative anesthetic management matters. Anesthesiology 2005; 102: 251-2.
62. Harper NJN, Wallace M, Hall IA. Optimum dose of neostigmine at two levels of atracurium-induced neuromuscular block. British Journal of Anaesthesia 1994; 72: 82-5.
63. Beemer GH, Rozental P. Postoperative neuromuscular function. Anaesthesia and Intensive Care 1986; 14: 41-5.
64. Magorian T, Lynam DP, Caldwell JE, Miller RD. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? Anesthesiology 1990; 73: 410-4.
65. Beemer GH, Bjorksten AR, Dawson PJ, Dawson RJ, Heenan PJ, Robertson BA. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. British Journal of Anaesthesia 1991; 66: 469-75.
66. Kopman AF, Kopman DJ, Ng J, Zank LM. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function. Journal of Clinical Anesthesia 2005; 17: 30-5.